Literature DB >> 14989224

FDG-PET: procedure guidelines for tumour imaging.

Emilio Bombardieri1, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Mortelmans, Sven N Reske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14989224     DOI： 10.1007/s00259-003-1355-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  60 in total

1.  Performance evaluation of PET scanners: testing of geometric arc correction by off-centre uniformity measurement.

Authors:  R Buchert; K H Bohuslavizki; H Fricke; J Mester; M Clausen
Journal:  Eur J Nucl Med       Date:  2000-01

2.  [New dietary guidelines before FDG-PET, or how to simply improve validity].

Authors:  J Margery; G Bonardel; F Vaylet; J Guigay; J-F Gaillard; P L'Her
Journal:  Rev Pneumol Clin       Date:  2002-12

3.  Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1991

4.  PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.

Authors:  L K Griffeth; F Dehdashti; A H McGuire; D J McGuire; D J Perry; S M Moerlein; B A Siegel
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

5.  An alternative method to normalize clinical FDG studies.

Authors:  A Sandell; T Ohlsson; K Erlandsson; S E Strand
Journal:  J Nucl Med       Date:  1998-03       Impact factor: 10.057

6.  Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.

Authors:  C Bleckmann; J Dose; K H Bohuslavizki; R Buchert; S Klutmann; J Mester; F Jänicke; M Clausen
Journal:  J Nucl Med       Date:  1999-12       Impact factor: 10.057

7.  Infection imaging using whole-body FDG-PET.

Authors:  K D Stumpe; H Dazzi; A Schaffner; G K von Schulthess
Journal:  Eur J Nucl Med       Date:  2000-07

8.  Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Authors:  W A Weber; S I Ziegler; R Thödtmann; A R Hanauske; M Schwaiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

9.  Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model.

Authors:  A Bertoldo; P Peltoniemi; V Oikonen; J Knuuti; P Nuutila; C Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-09       Impact factor: 4.310

10.  Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer.

Authors:  W A Hallett; P K Marsden; B F Cronin; M J O'Doherty
Journal:  Eur J Nucl Med       Date:  2001-07
View more
  17 in total

Review 1.  PET/CT and breast cancer.

Authors:  Barbara Zangheri; Cristina Messa; Maria Picchio; Luigi Gianolli; Claudio Landoni; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-05       Impact factor: 9.236

2.  Effects of various anesthetic protocols on 18F-flurodeoxyglucose uptake into the brains and hearts of normal miniature pigs (Sus scrofa domestica).

Authors:  Young Ah Lee; Jong-In Kim; Jae-Won Lee; Yoon Ju Cho; Byeong Han Lee; Hyun Woo Chung; Keun-Kyu Park; Jin Soo Han
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

Review 3.  Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Authors:  James Rieffel; Upendra Chitgupi; Jonathan F Lovell
Journal:  Small       Date:  2015-07-16       Impact factor: 13.281

4.  The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis.

Authors:  Wolfgang Peter Mueller; Henriette Ingrid Melzer; Irene Schmid; Eva Coppenrath; Peter Bartenstein; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-25       Impact factor: 9.236

5.  Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.

Authors:  David M Schuster; Cristina Nanni; Stefano Fanti; Shuntaro Oka; Hiroyuki Okudaira; Yusuke Inoue; Jens Sörensen; Rikard Owenius; Peter Choyke; Baris Turkbey; Trond V Bogsrud; Tore Bach-Gansmo; Raghuveer K Halkar; Jonathon A Nye; Oluwaseun A Odewole; Bital Savir-Baruch; Mark M Goodman
Journal:  J Nucl Med       Date:  2014-11-13       Impact factor: 10.057

6.  Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.

Authors:  Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Germano Perotti; Chiara de Waure; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Monica Santimaria; Annibale Versari; Stefano Fanti; Alessandro Giordano; Vittoria Rufini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-06       Impact factor: 9.236

7.  Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification.

Authors:  Toshihiko Masui; Ryuichiro Doi; Tatsuo Ito; Kazuhiro Kami; Kohei Ogawa; Daisuke Harada; Shinji Uemoto
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

8.  Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology.

Authors:  J Stauss; C Franzius; T Pfluger; K U Juergens; L Biassoni; J Begent; R Kluge; H Amthauer; T Voelker; L Højgaard; S Barrington; S Hain; T Lynch; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 9.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

10.  Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience.

Authors:  Dong Hwan Kim; Seung Yeon Kim; Hyeon Jeong Lee; Bong Sup Song; Dong Ho Kim; Joong Bum Cho; Jung Sub Lim; Jun Ah Lee
Journal:  Cancer Res Treat       Date:  2011-09-30       Impact factor: 4.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.